Clinical trial
The Effects of Metformin on Blood Vessel Structure and Function
NCT00105066 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00105066 |
|---|---|
| Title | The Effects of Metformin on Blood Vessel Structure and Function |
| Official title | The Effects of Metformin on Vascular Structure and Function in Subjects With the Metabolic Syndrome (MET Trial) |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity, Hypertension, Hypercholesterolemia, Hyperglycemia |
| Intervention type | Drug |
| Interventions | Metformin, Placebo |
| Enrollment | 77 |
| Start date | Jan 1, 2004 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Mar 4, 2005 |
| Last update posted | Jan 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: